A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis
Summary
- Eligibility
- for people ages 2-17 (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedcompletion around
- Principal Investigator
- by Jonathan Strober
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UCSF
- Jonathan Strober
Professor, Neurology, School of Medicine. Authored (or co-authored) 63 research publications
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Janssen Research & Development, LLC
- ID
- NCT05265273
- Phase
- Phase 2/3 Myasthenia Gravis Research Study
- Study Type
- Interventional
- Participants
- Expecting 12 study participants
- Last Updated